蘇墾農發(601952.SH):併購宇宸麪粉項目立項
格隆匯12月23日丨蘇墾農發(601952.SH)公佈,2024年12月23日召開第四屆董事會第三十八次會議,審議通過了《關於併購宇宸麪粉項目立項的議案》,同意公司就併購宇宸麪粉項目進行立項,該項目中,公司擬以現金為對價,通過股權受讓和增資擴股相結合的方式投資控股宇宸麪粉,合計取得宇宸麪粉70%股權(以下簡稱“本次股權投資事項”)。本次股權投資事項的交易價格將以公司聘請的評估機構出具的評估報吿評估值及在國有資產監督管理部門備案的評估結果為依據,由各方協商在最終簽署的交易文件中明確。如本次股權投資事項完成,宇宸麪粉將成為公司控股子公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.